https://modernaesthetics.com/articles/2024-jan-feb/the-art-of-software-design-in-dermatology-and-aesthetic-medicine/pdf
You can download the PDF also HERE
This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion.
Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
avisé labs is also attending this event in person in 2024 to establish new partnerships for innovative medical applications fostered by intelligent software approaches. We are looking forward to connecting with you at Stanford!
Link to the conference:
https://med.stanford.edu/cvi/events/2024-drug-discovery-conference.html
This year, NVIDIA, Intel and twelve renowned venture capital firms (Cherry Ventures, Earlybird Capital, UVC Partners, Yttrium, Lakestar, High-Tech Founder Funds, eCAPITAL, La Famiglia, Asgard, Burda Principal Investments, HV Capital, and Born2Grow), participated in the selection process of the most promising AI Startups in Germany. You can find further information about the selection process as well as the detailed analysis of the German AI Startup Landscape here.
The AI Startup Landscape is Germany’s most comprehensive and respected analysis of the AI startup scene, highlighting the incredible work being done by AI Startups across various enterprise functions, intelligence, technology types, and industries. This year, the AI Startup Landscape was covered in several articles in the WirtschaftsWoche (Link to Article 1 | Link to Article 2 | Link to Article 3).
The appliedAI Institute, along with their esteemed partners from academia, government, and industry, has been dedicated to creating an ecosystem where AI startups can thrive and contribute to shaping the future of AI for the betterment of society. One of their key objectives is to facilitate partnerships and collaboration opportunities between startups and corporations to enhance knowledge sharing and foster AI adoption.
To support this endeavor, the appliedAI Institute has developed a centralized database of high-quality and externally validated AI startups. This platform aims to provide easy access for corporations, SMEs, and governmental institutions to connect with trusted AI partners.
We are thrilled that the appliedAI Institute and their partners selected avisé labs as one of the most promising AI Startups in Germany!
We are proud of being part of the AI Startup Landscape and are looking forward to great collaborations and future projects within the AI startup community!
April 24-25, 2023: Stanford University, USA: >>The SDDS provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care.<<
avisé labs is attending this event in person to establish new partnerships towards innovative medical applications that are fostered by intelligent software approaches.
We are looking forward to get connected with you in Stanford!
Link to the conference:
https://med.stanford.edu/cvi/events/2023-drug-discovery-conference.html
avisé labs is excited to be part of the next 5CC World Congress. This year virtual, we share our experience within the Session „The Brain behind the Brain – Optimizing Results with AI & Deep Learning“.
Especially in the complex medical domain it is crucial to work with an interdisciplinary team. Researchers, Clinicians, Computer Scientists – we all need to work together to achieve new insights in the medical field, powered by AI.
We are looking forward to discussing and to get to know new findings in the field of Medicine & AI.
Join us August 28 – 30, 2020
More Information can be found here: https://www.5-cc.com/en/home/
avisé labs attended the 5 Continent Congress in Barcelona from August 29 – September 1, 2019.
Within the session ‚Decoding the Future of AI & Deep Learning in Dermatology‘ avisé CEO, Marius Khan, gave a talk with the title ‚The Beauty of AI: Intelligent Solutions for Decision Support in Aesthetic Medicine‘. They discussed the work of avisé and the importance of AI in aesthetic medicine.
